Author-it Software Corporation

Author-it is a private enterprise software company that develops component content management and structured authoring platforms. Its core products include Author-it CCMS for technical and regulated content workflows and Docuvera for life sciences documentation, including the authoring, review, approval, translation, and publishing of regulated pharmaceutical content. The business serves documentation-intensive industries such as software, manufacturing, utilities, and life sciences, with a particular healthcare-facing use case in pharma regulatory and medical content operations. Rather than developing therapeutics, Author-it provides commercial SaaS and services that help organizations manage compliant, reusable content at scale. The company appears to remain operational following a strategic investment/acquisition transaction involving Bertelsmann Investments in 2023.